Background: Lymphomatoid granulomatosis is a rare disorder of the central nervous system (CNS) with few cases being reported in literature. We present the case of an adult with an unusual lesion of the CNS who presented with motor seizures and was diagnosed with lymphomatoid granulomatosis, followed by a discussion of the process of evaluation and management. Case Description: A 42-year-old male presented with motor seizures and loss of consciousness for 10 minutes along with dysarthria and left hemiplegia. Neurological examination and imaging with magnetic resonance imaging (MRI) of the brain revealed a mass in the right striatum. The patient was hospitalized and underwent an image-guided right frontal craniotomy using the Leksell Stereotactic G-Frame. Pathology reported a lymphomatoid granulomatosis. Being immunocompetent, the patient received medical treatment with prednisone and rituximab. Two years after his diagnosis, the patient had no active disease and his brain MRI did not show contrast enhancement. After almost 3 years of follow-up, the patient has a mild weakness in the left-side of his body (4/5), is seizure-free, and can walk and perform daily activities. Conclusions: This rare lesion in an adult, immunocompetent patient, debuting with motor seizures represents a challenge in terms of diagnosis and treatment. After surgical and medical treatment, the patient had a satisfactory recovery. Clinical features, imaging, differential diagnosis, and pathology are discussed.
INTRODUCTION
Lymphomatoid granulomatosis (LG) is a disease that was first described in 1972 by Liebow et al., [13] however, little is known about the disease. It is a lymphoproliferative angiodestructive systemic disease associated with the Epstein-Barr virus. It mainly affects the lungs (80%) but it has also been described to involve other organs such as the skin (40%) and the central nervous system (CNS) (20%). [8, 10] Because there is still much to be learned about this disease, we present the following case along with a detailed description of its radiological, pathological, and clinical findings.
CASE REPORT
A 42-year-old man, previously healthy, was living with his step father and other members of an extended family in a small farm. He presented with a first episode of a motor seizure that started on the left side of his body before becoming generalized. Shortly afterwards, he noticed left hemiparesis and dysarthria; he was admitted to our institution through the emergency department.
After a physical examination, magnetic resonance imaging (MRI) of the patient revealed a well-defined, spherical lesion, located in the superior aspect of the anterior limb of the internal capsule and right striatum, with surrounding edema [ Figure 1 ]. Laboratory studies found no systemic compromise and no underlying immunocompromise. We decided to excise and analyze the aforementioned lesion. Performing an image-guided frontal craniotomy, using the Leksell Stereotactic G-Frame (Elekta Instruments AB, Stockholm, Sweden), we planned the trajectory to avoid the head of the caudate nucleus, the genu of the internal capsule, the putamen, and other critical structures. The mass was completely excised and the thalamostriate vein, which was adhered to the mass, was preserved. Craniotomy was performed, instead of a stereotactic biopsy, because we suspected the lesion to be a high-grade glioma that was accessible to surgical resection.
In the pathological analysis, there was an evident atypical T and B infiltrate; morphological and phenotypical characteristics of Grade 1 lymphomatoid granulomatosis. The patient was subjected to thoracic and abdominal screening, which revealed paratracheal, jugular, and inguinal adenopathies, but no other masses.
After consulting with the hematology group, the patient received a four-cycle medical treatment with rituximab and prednisone. Clinically, he recovered almost completely with strength of 4/5 and complete reintegration to his daily activities, which involved bimanual work. Six months after his diagnosis, a new MRI showed the absence of new or residual lesions. Intraparenchymal lesions, which may be unifocal or multifocal, supra or infratentorial [3, 22] Solitary lesions located in the cerebral parenchyma, most cases are supratentorial (75-81%), with a small percentage affecting the leptomeninges [1, 7, 21] Lesions with solid or ring-like enhancement, with variable degree of edema associated with leptomeningeal enhancement [3, 22] In immunocompetent patients, 90% have a homogeneous enhancement and 10% have a ring-like enhancement. In immunocompromised, patients there is irregular enhancement, and, in up to 75% of cases, ring-like enhancement [7, 11, 21] On T1-weigthed imaging, lesions have a low signal intensity, and varying intensities on T2 [7, 11, 21] MRI reveals lesions that appear as clearly delineated masses, iso to hypointense on T1, and mostly hypointense on T2 for immunocompetent patients [7, 11, 21] No favorable response to treatment with corticosteroids or chemotherapy
Favorable to response to treatment with chemotherapyr [13, 18] CNS: Central nervous system,MRI: Magnetic resonance imaging Two years after the surgery the patient continued to be free of seizures, and his MRI showed no evidence of new lesions, areas of restriction of diffusion, or anomalous enhancements that could indicate residual or recurrent tumor [ Figure 2 ].
DISCUSSION
LG is a lymphoproliferative disorder, in which tumorous B cells transform after infection with the Epstein-Barr virus. [4] This disease has a mortality rate of 60-90% and cerebral involvement occurs in 30% of cases. Primary CNS involvement is rare, being higher in men (2:1) with or without immunosuppression. [16, 19] The pathogenesis of LG is unknown. Studies based on clinicopathological, immunophenotypic, and clonal evidence have shown that this is a unique type of extranodal, malignant lymphoma. [12] Tumor cells are often found to be accompanied by plasmatic cells, immunoblastic lymphoid cells, small CD4+ T cells, and histiocytes. Occasionally, neutrophils and eosinophils are also found [ Figures 3 and 4] . [4] LG can be graded based on the relative amount of tumor reactive cells and accompanying tumor cells. [4, 14] When there is a predominance of small lymphocytes without cytological atypia, less than five Epstein-Barr virus (EBV) infected cells, and no necrosis, the condition may be said to be Grade 1. Grade 2 is characterized by a variable number of lymphoid cells transformed by EBV (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) and some necrosis. In Grade 3, there are more EBV-transformed cells (more than 20), some small lymphocytes, and larger areas of necrosis. [13, 19] Radiological, lymphomatoid granulomatosis (LG) appearance in a brain computed tomography (CT) varies. It is common to find intraparenchymal lesions, which may be unilateral or multifocal, supra or infratentorial. These lesions may appear as low-density areas within the cerebral white matter; they may be solid or ring-like, sometimes with accompanying edema. [22] Because of its angiocentric and angiodestructive character, LG can debut with intraparenchymal hemorrhage, stroke, or aneurysms. [4, 22] Cerebral angiography may reveal changes consistent with vasculitis. [22] LG and CNS lymphoma share similar radiological features that may be difficult to distinguish on an MRI or CT image [ Table 1 ].
Our patient, unlike what literature reports [ Table 2 ], responded well to chemotherapy with rituximab and prednisolone (4 cycles every 2 months). Whether tumor resection prior to chemotherapy is the cause of success or not in tumor control is a subject of discussion. Blood-brain barrier penetrance of rituximab is poor, which means a potential deficit in its CNS tumor control ability. [2] Several reports have mentioned rituximab to be a good option, however, it would be advisable to procure a total resection as in high-grade gliomas prior to chemotherapy. Is necessary to do further research to answer this question.
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